Kramer Anneke, Stel Vianda S, Tizard Jane, Verrina Enrico, Rönnholm Kai, Pálsson Runólfur, Maxwell Heather, Jager Kitty J
Department of Medical Informatics, ERA-EDTA Registry, Academic Medical Center, Amsterdam, The Netherlands.
Nephrol Dial Transplant. 2009 Mar;24(3):926-33. doi: 10.1093/ndt/gfn542. Epub 2008 Oct 7.
Little is known about the group of children on renal replacement therapy (RRT) who reach the age of 18 years and are transferred from paediatric to adult nephrology services. The aim of this study was to describe patient demographics, primary renal diseases, treatment history and determine the risk factors for mortality of these young adults who started RRT in childhood.
We included 1777 young adults who had started RRT during childhood and turned 18 between 1985 and 2004 from nine European renal registries submitting data to the ERA-EDTA Registry. The chi-square test was used to test differences between patient groups and Cox regression analysis to examine patient survival.
Young adults who began RRT during childhood increased the total number of adult patients starting RRT by 1.5% per annum. The annual number of children on RRT turning 18, per million persons (Pmarp) reaching the age of 18 years, increased between 1985 and 2004 from 71 to 116. Over time, there was an increase in the percentage of young adults who started RRT at a very young age, a greater number of children with hypoplasia/dysplasia and cystic kidneys and more young adults who started RRT with peritoneal dialysis or pre-emptive transplantation. The unadjusted 5-year patient survival from the 18th birthday was 95.1% (95% CI 93.9-96.0). The average life expectancy was 63 years for young adults with a functioning graft and 38 years for those remaining on dialysis.
The number Pmarp of young adults on RRT has increased over time. Their characteristics and treatment history changed. Their survival prospects are good; however, transplant recipients have an expected remaining lifetime that is at least twice as high as for young adults on dialysis.
对于接受肾脏替代治疗(RRT)并年满18岁且从小儿肾脏病服务转至成人肾脏病服务的儿童群体,人们了解甚少。本研究的目的是描述这些在儿童期开始接受RRT的年轻成人的患者人口统计学特征、原发性肾脏疾病、治疗史,并确定其死亡风险因素。
我们纳入了1777名在儿童期开始接受RRT且于1985年至2004年间年满18岁的年轻成人,这些数据来自向欧洲肾脏协会 - 欧洲透析与移植协会(ERA - EDTA)注册中心提交数据的九个欧洲肾脏登记处。采用卡方检验来检验患者组之间的差异,并使用Cox回归分析来检查患者的生存率。
在儿童期开始接受RRT的年轻成人使开始接受RRT的成年患者总数每年增加1.5%。每百万达到18岁的人群中(Pmarp),接受RRT且年满18岁的儿童数量在1985年至2004年间从71增加到116。随着时间的推移,在非常年幼时开始接受RRT的年轻成人比例有所增加,患有发育不全/发育异常和多囊肾的儿童数量增多,并且更多的年轻成人开始采用腹膜透析或抢先移植的方式接受RRT。从18岁生日起未经调整的5年患者生存率为95.1%(95%可信区间93.9 - 96.0)。有功能移植物的年轻成人的平均预期寿命为63岁,而仍接受透析的患者平均预期寿命为38岁。
接受RRT的年轻成人的Pmarp数量随时间增加。他们的特征和治疗史发生了变化。他们的生存前景良好;然而,移植受者的预期剩余寿命至少是接受透析的年轻成人的两倍。